Clinical evaluation of the automated Abbott RealTime SARS-CoV-2, Alinity m SARS-CoV-2, and Alinity m Resp-4-Plex assays
Open Access
- 22 October 2021
- journal article
- research article
- Published by Elsevier in Journal of Virological Methods
- Vol. 299, 114338
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs)Journal of Virological Methods, 2021
- Verification and Validation of SARS-CoV-2 Assay Performance on the Abbott m 2000 and Alinity m SystemsJournal of Clinical Microbiology, 2021
- The Limit of Detection Matters: The Case for Benchmarking Severe Acute Respiratory Syndrome Coronavirus 2 TestingClinical Infectious Diseases, 2021
- Analytic Sensitivity of 3 Nucleic Acid Detection Assays in Diagnosis of SARS-CoV-2 InfectionThe Journal of Applied Laboratory Medicine, 2020
- Improved molecular laboratory productivity by consolidation of testing on the new random-access analyzer Alinity mJournal of Laboratory Medicine, 2020
- Comparison of the analytical sensitivity of seven commonly used commercial SARS-CoV-2 automated molecular assaysJournal of Clinical Virology, 2020
- Direct Comparison of SARS-CoV-2 Analytical Limits of Detection across Seven Molecular AssaysJournal of Clinical Microbiology, 2020
- Large-Scale, In-House Production of Viral Transport Media To Support SARS-CoV-2 PCR Testing in a Multihospital Health Care Network during the COVID-19 PandemicJournal of Clinical Microbiology, 2020
- Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performanceJournal of Clinical Virology, 2020
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCREurosurveillance, 2020